Tržní kapitalizace společnosti Akari Therapeutics Plc

Jaká je hodnota metriky Tržní kapitalizace společnosti Akari Therapeutics Plc?

Hodnota metriky Tržní kapitalizace společnosti Akari Therapeutics Plc je $21.42M

Jaká je definice metriky Tržní kapitalizace?

Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .

As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.

Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.

The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.

Čemu se věnuje společnost Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Firmy s metrikou tržní kapitalizace podobnou společnosti Akari Therapeutics Plc

  • Hodnota metriky Tržní kapitalizace společnosti U10 Corp je $21.35M
  • Hodnota metriky Tržní kapitalizace společnosti TDb Split je $21.35M
  • Hodnota metriky Tržní kapitalizace společnosti SPORTTOTAL AG je $21.39M
  • Hodnota metriky Tržní kapitalizace společnosti Gillanders Arbuthnot and je $21.39M
  • Hodnota metriky Tržní kapitalizace společnosti Grid Metals je $21.40M
  • Hodnota metriky Tržní kapitalizace společnosti Jayride je $21.41M
  • Hodnota metriky Tržní kapitalizace společnosti Akari Therapeutics Plc je $21.42M
  • Hodnota metriky Tržní kapitalizace společnosti Shri Bajrang Alloys je $21.43M
  • Hodnota metriky Tržní kapitalizace společnosti Indian Acrylics je $21.43M
  • Hodnota metriky Tržní kapitalizace společnosti e Tera SA je $21.43M
  • Hodnota metriky Tržní kapitalizace společnosti Dolphin Entertainment je $21.45M
  • Hodnota metriky Tržní kapitalizace společnosti Compucom Software je $21.46M
  • Hodnota metriky Tržní kapitalizace společnosti The Byke Hospitality je $21.48M